{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:02:05Z","timestamp":1792450925350,"version":"4.5.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.neuropharm.2008.06.046","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T04:53:20Z","timestamp":1214888000000},"page":"977-985","source":"Crossref","is-referenced-by-count":158,"title":["Transcriptional regulation at a HTR1A polymorphism associated with mental illness"],"prefix":"10.1016","volume":"55","author":[{"given":"Brice","family":"Le Fran\u00e7ois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Czesak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Steubl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.06.046_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0893-133X(96)80055-8","article-title":"The 5-HT1A receptor: signaling, desensitization, and gene transcription","volume":"14","author":"Albert","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1073858404267382","article-title":"5-HT1A receptors, gene repression, and depression: guilt by association","volume":"10","author":"Albert","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0898-6568(01)00259-5","article-title":"G protein specificity: traffic direction required","volume":"14","author":"Albert","year":"2002","journal-title":"Cell Signal."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib4","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1523\/JNEUROSCI.5156-05.2006","article-title":"Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter","volume":"26","author":"Alexandre","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(99)01309-7","article-title":"Neurotrophins and depression","volume":"20","author":"Altar","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00702-007-0705-9","article-title":"Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression","volume":"114","author":"Anttila","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0893-133X(01)00310-4","article-title":"Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims","volume":"25","author":"Arango","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.mp.4001146","article-title":"Analysis of structural polymorphisms and C\u22121018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression","volume":"7","author":"Arias","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0269881105049037","article-title":"Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram","volume":"19","author":"Arias","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-6147(00)01682-5","article-title":"How does pindolol improve antidepressant action?","volume":"22","author":"Artigas","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0306-4522(02)00289-0","article-title":"Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide","volume":"114","author":"Austin","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0006-8993(02)03727-7","article-title":"The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain","volume":"959","author":"Aznar","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2005.035709","article-title":"The CC2D1A, a member of a new gene family with C2 domains, is involved in autosomal recessive non-syndromic mental retardation","volume":"43","author":"Basel-Vanagaite","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2008.03.001","article-title":"Serotonin receptor 1A \u22121019C\/G variant: impact on antidepressant pharmacoresponse in melancholic depression?","volume":"436","author":"Baune","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.neuint.2007.08.021","article-title":"An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[(11)C]methyl-l-tryptophan PET study","volume":"52","author":"Berney","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib18","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/art.22135","article-title":"Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A \u22121019 G allele","volume":"54","author":"Birmingham","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib20","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1016\/S0893-133X(99)00036-6","article-title":"Serotonin and drug-induced therapeutic responses in major depression, obsessive\u2013compulsive and panic disorders","volume":"21","author":"Blier","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT(1A) agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpsychires.2007.05.004","article-title":"Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides","volume":"42","author":"Boldrini","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/89675","article-title":"The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation","volume":"8","author":"Bottomley","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/19315","article-title":"Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling","volume":"398","author":"Briscoe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF00172786","article-title":"Binding properties of the naturally occurring human 5-HT1A receptor variant with the Ile28Val substitution in the extracellular domain","volume":"352","author":"Bruss","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01213011-200504000-00009","article-title":"The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction","volume":"15","author":"Bruss","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib28","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1242\/dev.127.11.2323","article-title":"Hes genes regulate sequential stages of neurogenesis in the olfactory epithelium","volume":"127","author":"Cau","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0028-3908(94)90177-5","article-title":"The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex","volume":"33","author":"Ceci","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib30","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.21-24-09917.2001","article-title":"Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors","volume":"21","author":"Celada","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.me.41.020190.002253","article-title":"Serotonin-specific drugs for anxiety and depressive disorders","volume":"41","author":"Charney","year":"1990","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000080955","article-title":"Association analysis for the C\u22121019G promoter variant of the 5-HT1A receptor gene with auditory evoked potentials in major depression","volume":"50","author":"Chen","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(97)13468-1","article-title":"QEHA27, a peptide that binds to G-protein beta gamma-subunits, reduces the inhibitory effect of 5-HT on the Ca2+ current of rat dorsal raphe neurons","volume":"224","author":"Chen","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0896-6273(03)00195-8","article-title":"Finding the intracellular signaling pathways affected by mood disorder treatments","volume":"38","author":"Coyle","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.mp.4001457","article-title":"In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice","volume":"9","author":"Cryan","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib36","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1523\/JNEUROSCI.2643-05.2006","article-title":"Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism","volume":"26","author":"Czesak","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1601-183X.2006.00297.x","article-title":"Serotonergic genes modulate amygdala activity in major depression","volume":"6","author":"Dannlowski","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib38","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1523\/JNEUROSCI.3769-04.2005","article-title":"A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans","volume":"25","author":"David","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neuroscience.2007.04.004","article-title":"Embryonic and postnatal development of the serotonergic raphe system and its target regions in 5-HT(1A) receptor deletion or overexpressing mouse mutants","volume":"147","author":"Deng","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.AOG.0000284448.73490.ac","article-title":"Serotonin receptor 1A C(\u22121019)G polymorphism associated with premenstrual dysphoric disorder","volume":"110","author":"Dhingra","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nn1104","article-title":"Lmx1b is essential for the development of serotonergic neurons","volume":"6","author":"Ding","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S1461145705005869","article-title":"Association of the functional \u22121019C\/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder","volume":"9","author":"Domschke","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib43","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0140-6736(99)03121-9","article-title":"Depressive illness","volume":"354","author":"Doris","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib44","article-title":"5\u2013HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies","author":"Drago","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0969-8051(00)00119-0","article-title":"Serotonin type-1A receptor imaging in depression","volume":"27","author":"Drevets","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.nucmedbio.2007.06.008","article-title":"Serotonin-1A receptor imaging in recurrent depression: replication and literature review","volume":"34","author":"Drevets","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib47","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1073\/pnas.0601992103","article-title":"Fluoxetine targets early progenitor cells in the adult brain","volume":"103","author":"Encinas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0896-6273(00)00112-4","article-title":"Major depressive disorder","volume":"28","author":"Fava","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib49","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nn1780","article-title":"Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity","volume":"9","author":"Fisher","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.ypg.0000199443.69668.b1","article-title":"Interaction of serotonergic and noradrenergic gene variants in panic disorder","volume":"16","author":"Freitag","year":"2006","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib51","first-page":"1128","article-title":"Differential effects of paroxetine on raphe and cortical 5-HT(1A) binding: A PET study in monkeys","volume":"46","author":"Giovacchini","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/NMM:5:1:027","article-title":"The serotonergic system and anxiety","volume":"5","author":"Gordon","year":"2004","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrn871","article-title":"Specification of catecholaminergic and serotonergic neurons","volume":"3","author":"Goridis","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/416396a","article-title":"Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult","volume":"416","author":"Gross","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib55","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/j.1460-2075.1996.tb00547.x","article-title":"DEAF-1, a novel protein that binds an essential region in a Deformed response element","volume":"15","author":"Gross","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib56","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1523\/JNEUROSCI.18-23-10150.1998","article-title":"Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors","volume":"18","author":"Haddjeri","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib57","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/MCB.24.5.2074-2082.2004","article-title":"Defective neural tube closure and anteroposterior patterning in mice lacking the LIM protein LMO4 or its interacting partner Deaf-1","volume":"24","author":"Hahm","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib58","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.bjp.0702510","article-title":"Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat","volume":"126","author":"Hajos","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib59","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.1071829","article-title":"Serotonin transporter genetic variation and the response of the human amygdala","volume":"297","author":"Hariri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib60","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.biopsych.2007.02.015","article-title":"5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression","volume":"62","author":"Hasler","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib61","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.npp.1300506","article-title":"Discovering endophenotypes for major depression","volume":"29","author":"Hasler","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib62","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1242\/dev.01436","article-title":"Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation","volume":"131","author":"Hatakeyama","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib63","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1073\/pnas.95.25.15049","article-title":"Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice","volume":"95","author":"Heisler","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0896-6273(02)01167-4","article-title":"Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior","volume":"37","author":"Hendricks","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026988110001400208","article-title":"Serotonin autoreceptor function and antidepressant drug action","volume":"14","author":"Hjorth","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.tpj.6500340","article-title":"Response to fluoxetine and serotonin 1A receptor (C\u22121019G) polymorphism in Taiwan Chinese major depressive disorder","volume":"6","author":"Hong","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1471-4159.2003.01987.x","article-title":"Attenuated 5-HT1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase","volume":"87","author":"Hsiung","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib68","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archpsyc.64.7.783","article-title":"Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression","volume":"64","author":"Hu","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib69","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1461145704004663","article-title":"Human 5-HT1A receptor C(\u22121019)G polymorphism and psychopathology","volume":"7","author":"Huang","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib70","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1210\/me.12.10.1619","article-title":"Characterization of a nuclear deformed epidermal autoregulatory factor-1 (DEAF-1)-related (NUDR) transcriptional regulator protein","volume":"12","author":"Huggenvik","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib71","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1101\/gad.9.24.3136","article-title":"Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix\u2013loop\u2013helix factors, premature neurogenesis, and severe neural tube defects","volume":"9","author":"Ishibashi","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2008.03.007","article-title":"HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: essential role in developmental expression","author":"Jacobsen","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib73","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.mp.4001920","article-title":"Serotonergic vulnerability and depression: assumptions, experimental evidence and implications","volume":"12","author":"Jans","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.cr.7290016","article-title":"The Notch\u2013Hes pathway in mammalian neural development","volume":"9","author":"Kageyama","year":"1999","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib75","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.yexcr.2005.03.015","article-title":"Roles of bHLH genes in neural stem cell differentiation","volume":"306","author":"Kageyama","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib76","doi-asserted-by":"crossref","first-page":"8398","DOI":"10.1523\/JNEUROSCI.0618-06.2006","article-title":"Calcium activation of the LMO4 transcription complex and its role in the patterning of thalamocortical connections","volume":"26","author":"Kashani","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-8993(96)01141-9","article-title":"Characterization of the K+ current mediated by 5-HT1A receptor in the acutely dissociated rat dorsal raphe neurons","volume":"745","author":"Katayama","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib78","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.62.5.529","article-title":"The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication","volume":"62","author":"Kendler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1744-9081-2-7","article-title":"The C(\u22121019)G 5-HT1A promoter polymorphism and personality traits: no evidence for significant association in alcoholic patients","volume":"2","author":"Koller","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib80","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2007.02.053","article-title":"Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C","volume":"132","author":"Kraus","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molbrainres.2004.06.028","article-title":"Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors","volume":"129","author":"Kusserow","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib82","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.mp.4001680","article-title":"Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women","volume":"10","author":"Lee","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib83","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.mcn.2004.04.010","article-title":"The LIM domain-only protein LMO4 is required for neural tube closure","volume":"28","author":"Lee","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145704004699","article-title":"Association of the C(\u22121019)G 5-HT1A functional promoter polymorphism with antidepressant response","volume":"7","author":"Lemonde","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib85","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1523\/JNEUROSCI.23-25-08788.2003","article-title":"Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide","volume":"23","author":"Lemonde","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2008.02.005","article-title":"Association of serotonin-1A and 2A receptor promoter polymorphisms with depressive symptoms and functional recovery in elderly persons after hip fracture","author":"Lenze","year":"2008","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib87","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF03256237","article-title":"Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness","volume":"11","author":"Levin","year":"2007","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib89","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.mp.4001797","article-title":"Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR","volume":"11","author":"Lim","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib90","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990\u20132020","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib91","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biopsych.2003.09.017","article-title":"Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia","volume":"55","author":"Lopez-Figueroa","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib92","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib93","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nrn1220","article-title":"Neurobiology of suicidal behaviour","volume":"4","author":"Mann","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib94","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00702-007-0713-9","article-title":"Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs","volume":"114","author":"Marziniak","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib95","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1074\/jbc.M007629200","article-title":"Association with the nuclear matrix and interaction with Groucho and RUNX proteins regulate the transcription repression activity of the basic helix loop helix factor Hes1","volume":"276","author":"McLarren","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib96","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1471-4159.2007.04448.x","article-title":"Plasticity of 5-HT 1A receptor-mediated signaling during early postnatal brain development","volume":"101","author":"Mehta","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib97","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/sj.npp.1300556","article-title":"Serotonin 1A receptor binding and treatment response in late-life depression","volume":"29","author":"Meltzer","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib98","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nrn1993","article-title":"Intermediate phenotypes and genetic mechanisms of psychiatric disorders","volume":"7","author":"Meyer-Lindenberg","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib99","doi-asserted-by":"crossref","first-page":"30510","DOI":"10.1074\/jbc.274.43.30510","article-title":"Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2\/B1 promoter","volume":"274","author":"Michelson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejphar.2004.07.038","article-title":"The role of monoamines in the actions of established and \u201cnovel\u201d antidepressant agents: a critical review","volume":"500","author":"Millan","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib101","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/026988110201600311","article-title":"Repeated administration of milnacipran induces rapid desensitization of somatodendritic 5-HT1A autoreceptors but not postsynaptic 5-HT1A receptors","volume":"16","author":"Mochizuki","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib102","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0893-133X(00)00161-5","article-title":"Clinical and physiological consequences of rapid tryptophan depletion","volume":"23","author":"Moore","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib103","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.fertnstert.2007.03.059","article-title":"Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study","volume":"89","author":"Moses-Kolko","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib104","article-title":"Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression","author":"Neff","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib105","first-page":"99","article-title":"Tryptophan depletion, serotonin, and depression: where do we stand?","volume":"37","author":"Neumeister","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib106","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1523\/JNEUROSCI.4921-03.2004","article-title":"Reduced serotonin type 1A receptor binding in panic disorder","volume":"24","author":"Neumeister","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib107","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ajhg.2008.01.021","article-title":"CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa","volume":"82","author":"Noor","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib108","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1152\/jn.1994.71.6.2161","article-title":"5-HT1A receptor linked to inward-rectifying potassium current in hippocampal CA3 pyramidal cells","volume":"71","author":"Okuhara","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib109","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1073\/pnas.95.18.10734","article-title":"Increased anxiety of mice lacking the serotonin1A receptor","volume":"95","author":"Parks","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib110","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1074\/jbc.271.8.4417","article-title":"The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1","volume":"271","author":"Parks","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1176\/appi.ajp.163.1.48","article-title":"Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain","volume":"163","author":"Parsey","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib112","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.npp.1300992","article-title":"Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study","volume":"31","author":"Parsey","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib113","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1471-4159.2001.00254.x","article-title":"5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission","volume":"77","author":"Parsons","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib114","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.devbrainres.2005.03.006","article-title":"Ontogeny of 5-HT1A receptor expression in the developing hippocampus","volume":"157","author":"Patel","year":"2005","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nn1247","article-title":"Ascl1\/Mash1 is required for the development of central serotonergic neurons","volume":"7","author":"Pattyn","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib116","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0031-6997(24)01417-0","article-title":"Autoregulation of serotonin neurons: role in antidepressant drug action","volume":"51","author":"Pineyro","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib117","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biopsych.2006.09.022","article-title":"Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study","volume":"62","author":"Praschak-Rieder","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib118","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/sj.npp.1300472","article-title":"Preferential 5-HT(1A) autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression?","volume":"29","author":"Rabiner","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib119","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1073\/pnas.95.24.14476","article-title":"Serotonin receptor 1A knockout: an animal model of anxiety-related disorder","volume":"95","author":"Ramboz","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00267-X","article-title":"Toward a molecular architecture of personality","volume":"139","author":"Reif","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib121","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1176\/appi.ajp.163.10.1826","article-title":"Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients","volume":"163","author":"Reynolds","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib122","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A","article-title":"Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain","volume":"417","author":"Riad","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib123","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/jnr.21277","article-title":"The Freud-1\/CC2D1A family: transcriptional regulators implicated in mental retardation","volume":"85","author":"Rogaeva","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib124","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S1461145703004061","article-title":"Association of a functional 1019CG 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia","volume":"7","author":"Rothe","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0893-133X(97)00021-3","article-title":"Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor","volume":"17","author":"Rotondo","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib126","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.0953-816X.2004.03194.x","article-title":"Adaptation of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP","volume":"19","author":"Rumajogee","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib127","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nn1969","article-title":"Adult hippocampal neurogenesis in depression","volume":"10","author":"Sahay","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib128","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.57.2.174","article-title":"Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment","volume":"57","author":"Sargent","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib130","first-page":"208","article-title":"Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior","volume":"64","author":"Sawiniec","year":"2007","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib131","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.7871435","article-title":"The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes","volume":"267","author":"Schoenherr","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib132","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S1461145704004687","article-title":"The C(\u22121019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings","volume":"7","author":"Serretti","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib133","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib134","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajmg.b.30432","article-title":"HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers","volume":"144","author":"Serretti","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/syn.10204","article-title":"No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET","volume":"48","author":"Shioe","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib136","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1460-9568.1990.tb00026.x","article-title":"Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei","volume":"2","author":"Sotelo","year":"1990","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib137","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib138","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1523\/JNEUROSCI.18-18-07394.1998","article-title":"Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity","volume":"18","author":"Stockmeier","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib139","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1046\/j.1471-4159.1999.0722238.x","article-title":"TATA-driven transcriptional initiation and regulation of the rat serotonin 5-HT1A receptor gene","volume":"72","author":"Storring","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib140","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00702-003-0072-0","article-title":"Allelic variation in 5-HT(1A) receptor expression is associated with anxiety- and depression-related personality traits","volume":"110","author":"Strobel","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib141","doi-asserted-by":"crossref","first-page":"15418","DOI":"10.1073\/pnas.95.26.15418","article-title":"Mouse deformed epidermal autoregulatory factor 1 recruits a LIM domain factor, LMO-4, and CLIM coregulators","volume":"95","author":"Sugihara","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib142","article-title":"Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder","author":"Szewczyk","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib143","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/138945006775515464","article-title":"Catecholaminergic strategies for the treatment of major depression","volume":"7","author":"Tremblay","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib144","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib145","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1128\/MCB.24.5.2063-2073.2004","article-title":"Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1\/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice","volume":"24","author":"Tse","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib146","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hbm.20035","article-title":"Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain","volume":"22","author":"Varnas","year":"2004","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib147","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ajmg.b.30390","article-title":"Association study of seven polymorphisms in four serotonin receptor genes on suicide victims","volume":"141","author":"Videtic","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib148","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1523\/JNEUROSCI.3632-07.2008","article-title":"Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib149","doi-asserted-by":"crossref","DOI":"10.1177\/0269881107081522","article-title":"The \u22121019 C\/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients","author":"Wang","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1744-9081-2-14","article-title":"The serotonin 1A receptor C(\u22121019)G polymorphism in relation to suicide attempt","volume":"2","author":"Wasserman","year":"2006","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib151","series-title":"The World Health Report 2001. Mental Health, New Understanding, New Hope","author":"WHO","year":"2001"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib152","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041444-199906000-00010","article-title":"A common C\u22121018G polymorphism in the human 5-HT1A receptor gene","volume":"9","author":"Wu","year":"1999","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib153","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1468-1331.2006.01281.x","article-title":"No association of C\u22121019G promoter polymorphism of 5-HT1A receptor gene with migraine","volume":"13","author":"Yang","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib154","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.euroneuro.2005.12.004","article-title":"Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders","volume":"16","author":"Yu","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib155","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1176\/appi.ajp.163.9.1588","article-title":"Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression","volume":"163","author":"Zalsman","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2008.06.046_bib156","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.euroneuro.2007.03.008","article-title":"Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression","volume":"17","author":"Zanardi","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.046_bib157","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1601-183X.2007.00353.x","article-title":"5-HT1A receptor gene C\u22121019 G polymorphism and amygdala volume in borderline personality disorder","volume":"7","author":"Zetzsche","year":"2008","journal-title":"Genes Brain Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T17:20:13Z","timestamp":1738257613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":157,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0028390808002438"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.046","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}